Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden : A multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)

✍ Scribed by Franck Morschhauser; Nicolas Mounier; Catherine Sebban; Pauline Brice; Phillippe Solal-Celigny; Herve Tilly; Pierre Feugier; Christophe Fermé; Marie Christine Copin; Thierry Lamy

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 219 KB
• Volume: 116
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.25280